Resistin-Like Molecule Beta (RELM- β) Regulates Proliferation of Human Diabetic Nephropathy Mesangial Cells via Mitogen-Activated Protein Kinases (MAPK) Signaling Pathway.

CONCLUSIONS The results provide evidence that RELM-b is a potential molecular target for the treatment of DN. PMID: 28801998 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research